Generation of novel trimeric fragments of human SP-A and SP-D after recombinant soluble expression in E. coli. (2020)
Attributed to:
Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.imbio.2020.151953
PubMed Identifier: 32747028
Publication URI: http://europepmc.org/abstract/MED/32747028
Type: Journal Article/Review
Volume: 225
Parent Publication: Immunobiology
Issue: 4
ISSN: 0171-2985